Antifibrinolytic drugs in the treatment of urinary tract haemorrhage.
D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000502:physiology / Q000652:urine; D006417:Hematuria / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D009325:Nausea / Q000139:chemically induced; D011183:Postoperative Complications / Q000517:prevention & control; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000150:complications; D001745:Urinary Bladder Diseases / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy*
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D006493:Heparin